Loading organizations...
Loading organizations...
Biotech company providing novel biomarker solutions for drug development.
Denovo Biopharma has raised $54.5M across 2 funding rounds.
Denovo Biopharma has raised $54.5M in total across 2 funding rounds.
Denovo Biopharma has raised $54.5M in total across 2 funding rounds.
Denovo Biopharma's investors include California Institute for Regenerative Medicine, Sangel Capital.
Denovo Biopharma has raised $54.5M across 2 funding rounds. Most recently, it raised $12.0M Other Equity in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 7, 2024 | $12.0M Other Equity | California Institute for Regenerative Medicine | |
| Oct 31, 2019 | $42.5M Series B | Sangel Capital |